HHS To Announce Final Plan For Coverage Of Patient Care Costs In All Clinical Trials.
White House Appoints Slamon To Cancer Panel; Brinker To Address Republican Convention.
Henry Brem Named Director Of Neurology At Johns Hopkins.
Cancer Groups Oppose Plan To Cut Drug Reimbursement.
Edward Benz Named President Of Dana-Farber Cancer Institute.
Univ. of Iowa Cancer Center Wins NCI Cancer Center Grant.
75% Of Fed Research Funds Pay Direct Costs, Study Says.
More Women Over 50 Report Having Had Mammograms.
US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.
FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.
Sweden Approves Photofrin For Palliation Of Two Cancers.
Firm Buys Rights To NKT Cells From Beth Israel Deaconess.
Trending Stories
- With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - Anthony Letai sworn in as 18th NCI director
- Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research
- Population-based cancer surveillance is a national treasure at risk
- Former NCI official’s nonprofit seeks to tell the stories of cancer patients
Patient Action for Cancer Research aims to show impact of federal research
